Clinical Trials Browser

Recruiting × Tretinoin × Breast × Clear all

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

NCT06731140 2025-11-17

Resilire

Phase 2 Recruiting

10 enrolled

Breast

HER2 Negative Breast Cancer

Clinical Trials

N01-A-PICIT-GT

Resilire